Starling Oncology (STLN) Gross Margin Growth (1y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.73 Bn | 89.71 Bn | 15.19 Bn | -454.00 |
| 2 | Tenet Healthcare | 22.05 Bn | 19.88 Bn | 4.45 Bn | 37.00 |
| 3 | Encompass Health | 12.13 Bn | 12.00 Bn | 1.34 Bn | -129.00 |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | -38.00 |
| 5 | Universal Health Services | 10.12 Bn | 9.98 Bn | 3.29 Bn | -201.00 |
| 6 | Ensign | 9.97 Bn | 9.64 Bn | 306.24 Mn | 41.00 |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn | 305.00 |
| 8 | Pacs | 6.73 Bn | 6.57 Bn | 338.46 Mn | 168.00 |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.14 Bn | 192.10 Mn | 238.00 |
| 10 | Starling Oncology | 613.55 Mn | 572.46 Mn | 27.17 Mn | 223.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 223.00 |
| Mar 31, 2026 | -71.00 |
| Dec 31, 2025 | -576.00 |
| Sep 30, 2025 | -53.00 |
| Jun 30, 2025 | -3,820.00 |
| Mar 31, 2025 | -3,119.00 |
| Dec 31, 2024 | 12,310.00 |
| Sep 30, 2024 | -3,081.00 |
| Jun 30, 2024 | 875.00 |
| Mar 31, 2024 | 391.00 |
| Dec 31, 2023 | -264.00 |
| Sep 30, 2023 | 79.00 |
| Jun 30, 2023 | -198.00 |
| Mar 31, 2023 | -656.00 |
| Dec 31, 2022 | -145.00 |
| Sep 30, 2022 | -703.00 |
| Jun 30, 2022 | -667.00 |
| Mar 31, 2022 | -211.00 |